Rapamycin and Zoledronic Acid strongly retard growth of advanced murine hepatocellular carcinoma via skewing and activation of innate and adaptive immunity

M Ashfaq-Khan; M Aslam; MA Qureshi; D Schuppan

doi:10.1055/s-0038-1668946

Zeitschrift für Gastroenterologie, Inhaltsverzeichnis

Z Gastroenterol 2018; 56(08): e311
DOI: 10.1055/s-0038-1668946

Kurzvorträge

Gastroenterologische Onkologie

HCC: Molekulare Grundlagen der Karzinogenese und des therapeutischen Targetings – Donnerstag, 13. September 2018, 12:00 – 13:52, 22b

Georg Thieme Verlag KG Stuttgart · New York

Rapamycin and Zoledronic Acid strongly retard growth of advanced murine hepatocellular carcinoma via skewing and activation of innate and adaptive immunity

M Ashfaq-Khan

¹Institute of Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Deutschland

,

M Aslam

¹Institute of Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Deutschland

,

MA Qureshi

¹Institute of Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Deutschland

,

D Schuppan

¹Institute of Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Deutschland

› Institutsangaben